Treatment . | Outcome . | Efficacy . | Drug/other treatment . | Source . |
---|---|---|---|---|
Depression | ||||
Treatment with older Antidepressants (TCA) | Remission | 29% | Amtriptyline (100 mg daily) | Arroll et al . (2005) ; Andrews et al . (2000) |
Disability | −31% | |||
Treatment with newer Antidepressants (SSRI) | Remission | 28% | Fluoxetine (20 mg daily) | Arroll et al . (2005) ; Andrews et al . (2000) |
Disability | −31% | |||
Psychotherapy | Remission | 28% | Cognitive therapy (16–20 h) | de Maat et al . (2007) ; Andrews et al . (2000) |
Disability | −31% | |||
Comibnation of AD and psychotherapy | Remission | 38% | Amtriptyline/Fluoxetine, cognitive therapy | de Maat et al . (2007) ; Andrews et al . (2000) |
Disability | −31% | |||
Proactive care | Remission | 38% | Amtriptyline/Fluoxetine, cognitive therapy | de Maat et al . (2007) ; Andrews et al . (2000) ; Geddes et al . (2003) |
Disability | −31% | |||
Incidence | −35% | |||
Schizophrenia | ||||
Older antipsychotics | Disability | −13% | Chlorpromazine 300 mg daily/Fluphenazine deconate 25 mg daily | Leutch et al . (1999) |
Newer antipsychotics | Disability | −14% | Risperidone 4 mg daily | Leutch et al . (1999) |
Older antipsychotics + psychosocial treatment | Disability | −23% | Chlorpromazine 100 mg daily/Fluphenazine deconate 25 mg daily, supportive psychosocial treatment | Mojtabai et al . (1998) ; Leutch et al . (1999) |
Newer antipsychotics + psychosocial treatment | Disability | −24% | Risperidone 4 mg daily, supportive psychosocial treatment | Mojtabai et al . (1998) ; Leutch et al . (1999) |
Case-management with older antipsychotics | Disability | −24% | Chlorpromazine 300 mg daily/Fluphenazine deconate 25 mg daily | Mojtabai et al . (1998) ; Leutch et al . (1999) |
Case-management with newer antipsychotics | Disability | −25% | Risperidone 4 mg daily | Mojtabai et al . (1998) ; Leutch et al . (1999) |
Bipolar disorder | ||||
Older mood stabilizer | Disability | −70% | Lithium Carbonate | Goodwin et al. (1990) ; Angst et al . (2000) ; Bowden et al . (2000) ; Tondo et al . (2001) |
Case-fatality | −65% | |||
Newer mood stabilizer | Disability | −65% | Sodium Valproate | Goodwin et al . (1990) ; Bowden et al 1994 ; Angst et al . (2000) ; Bowden et al . (2000) ; Tondo et al . (2001) |
Case-fatality | −65% | |||
Older Mood Stabilizer + psychosocial | Disability | −70% | Lithium Carbonate, supportive psychososial treatment | Goodwin et al . (1990) ; Angst et al. (2000) ; Bowden et al . (2000) ; Tondo et al . (2001) ; Lam et al. (2009) |
Case-fatality | −65% | |||
Newer mood stabilizer + psychosocial | Disability | −65% | Sodium Valproate, supportive psychosocial treatment | Goodwin et al. (1990) ; Bowden et al . (1994 , 2000) ; Angst et al . (2000) ; Tondo et al . (2001) ; Lam et al (2009) |
Case-fatality | −65% | |||
Epilepsy | ||||
Older antiepileptic | Remission | 60% | Phenobarbital 100 mg daily | Annegers et al . (1979) ; Goodridge, et al . (1983) ; Placenica et al . (1994) ; Cockerell et al . (1995) , Tudur Smith et al . (2009) |
Disability | −43% | |||
Newer antiepileptic | Remission | 60% | Carbamazepine 600 mg daily | Annegers et al . (1979) ; Goodridge et al . (1983) ; Placenica et al . (1994) ; Cockerell et al . (1995) , Tudur Smith et al . (2009) |
Disability | −43 % |
Treatment . | Outcome . | Efficacy . | Drug/other treatment . | Source . |
---|---|---|---|---|
Depression | ||||
Treatment with older Antidepressants (TCA) | Remission | 29% | Amtriptyline (100 mg daily) | Arroll et al . (2005) ; Andrews et al . (2000) |
Disability | −31% | |||
Treatment with newer Antidepressants (SSRI) | Remission | 28% | Fluoxetine (20 mg daily) | Arroll et al . (2005) ; Andrews et al . (2000) |
Disability | −31% | |||
Psychotherapy | Remission | 28% | Cognitive therapy (16–20 h) | de Maat et al . (2007) ; Andrews et al . (2000) |
Disability | −31% | |||
Comibnation of AD and psychotherapy | Remission | 38% | Amtriptyline/Fluoxetine, cognitive therapy | de Maat et al . (2007) ; Andrews et al . (2000) |
Disability | −31% | |||
Proactive care | Remission | 38% | Amtriptyline/Fluoxetine, cognitive therapy | de Maat et al . (2007) ; Andrews et al . (2000) ; Geddes et al . (2003) |
Disability | −31% | |||
Incidence | −35% | |||
Schizophrenia | ||||
Older antipsychotics | Disability | −13% | Chlorpromazine 300 mg daily/Fluphenazine deconate 25 mg daily | Leutch et al . (1999) |
Newer antipsychotics | Disability | −14% | Risperidone 4 mg daily | Leutch et al . (1999) |
Older antipsychotics + psychosocial treatment | Disability | −23% | Chlorpromazine 100 mg daily/Fluphenazine deconate 25 mg daily, supportive psychosocial treatment | Mojtabai et al . (1998) ; Leutch et al . (1999) |
Newer antipsychotics + psychosocial treatment | Disability | −24% | Risperidone 4 mg daily, supportive psychosocial treatment | Mojtabai et al . (1998) ; Leutch et al . (1999) |
Case-management with older antipsychotics | Disability | −24% | Chlorpromazine 300 mg daily/Fluphenazine deconate 25 mg daily | Mojtabai et al . (1998) ; Leutch et al . (1999) |
Case-management with newer antipsychotics | Disability | −25% | Risperidone 4 mg daily | Mojtabai et al . (1998) ; Leutch et al . (1999) |
Bipolar disorder | ||||
Older mood stabilizer | Disability | −70% | Lithium Carbonate | Goodwin et al. (1990) ; Angst et al . (2000) ; Bowden et al . (2000) ; Tondo et al . (2001) |
Case-fatality | −65% | |||
Newer mood stabilizer | Disability | −65% | Sodium Valproate | Goodwin et al . (1990) ; Bowden et al 1994 ; Angst et al . (2000) ; Bowden et al . (2000) ; Tondo et al . (2001) |
Case-fatality | −65% | |||
Older Mood Stabilizer + psychosocial | Disability | −70% | Lithium Carbonate, supportive psychososial treatment | Goodwin et al . (1990) ; Angst et al. (2000) ; Bowden et al . (2000) ; Tondo et al . (2001) ; Lam et al. (2009) |
Case-fatality | −65% | |||
Newer mood stabilizer + psychosocial | Disability | −65% | Sodium Valproate, supportive psychosocial treatment | Goodwin et al. (1990) ; Bowden et al . (1994 , 2000) ; Angst et al . (2000) ; Tondo et al . (2001) ; Lam et al (2009) |
Case-fatality | −65% | |||
Epilepsy | ||||
Older antiepileptic | Remission | 60% | Phenobarbital 100 mg daily | Annegers et al . (1979) ; Goodridge, et al . (1983) ; Placenica et al . (1994) ; Cockerell et al . (1995) , Tudur Smith et al . (2009) |
Disability | −43% | |||
Newer antiepileptic | Remission | 60% | Carbamazepine 600 mg daily | Annegers et al . (1979) ; Goodridge et al . (1983) ; Placenica et al . (1994) ; Cockerell et al . (1995) , Tudur Smith et al . (2009) |
Disability | −43 % |
Treatment . | Outcome . | Efficacy . | Drug/other treatment . | Source . |
---|---|---|---|---|
Depression | ||||
Treatment with older Antidepressants (TCA) | Remission | 29% | Amtriptyline (100 mg daily) | Arroll et al . (2005) ; Andrews et al . (2000) |
Disability | −31% | |||
Treatment with newer Antidepressants (SSRI) | Remission | 28% | Fluoxetine (20 mg daily) | Arroll et al . (2005) ; Andrews et al . (2000) |
Disability | −31% | |||
Psychotherapy | Remission | 28% | Cognitive therapy (16–20 h) | de Maat et al . (2007) ; Andrews et al . (2000) |
Disability | −31% | |||
Comibnation of AD and psychotherapy | Remission | 38% | Amtriptyline/Fluoxetine, cognitive therapy | de Maat et al . (2007) ; Andrews et al . (2000) |
Disability | −31% | |||
Proactive care | Remission | 38% | Amtriptyline/Fluoxetine, cognitive therapy | de Maat et al . (2007) ; Andrews et al . (2000) ; Geddes et al . (2003) |
Disability | −31% | |||
Incidence | −35% | |||
Schizophrenia | ||||
Older antipsychotics | Disability | −13% | Chlorpromazine 300 mg daily/Fluphenazine deconate 25 mg daily | Leutch et al . (1999) |
Newer antipsychotics | Disability | −14% | Risperidone 4 mg daily | Leutch et al . (1999) |
Older antipsychotics + psychosocial treatment | Disability | −23% | Chlorpromazine 100 mg daily/Fluphenazine deconate 25 mg daily, supportive psychosocial treatment | Mojtabai et al . (1998) ; Leutch et al . (1999) |
Newer antipsychotics + psychosocial treatment | Disability | −24% | Risperidone 4 mg daily, supportive psychosocial treatment | Mojtabai et al . (1998) ; Leutch et al . (1999) |
Case-management with older antipsychotics | Disability | −24% | Chlorpromazine 300 mg daily/Fluphenazine deconate 25 mg daily | Mojtabai et al . (1998) ; Leutch et al . (1999) |
Case-management with newer antipsychotics | Disability | −25% | Risperidone 4 mg daily | Mojtabai et al . (1998) ; Leutch et al . (1999) |
Bipolar disorder | ||||
Older mood stabilizer | Disability | −70% | Lithium Carbonate | Goodwin et al. (1990) ; Angst et al . (2000) ; Bowden et al . (2000) ; Tondo et al . (2001) |
Case-fatality | −65% | |||
Newer mood stabilizer | Disability | −65% | Sodium Valproate | Goodwin et al . (1990) ; Bowden et al 1994 ; Angst et al . (2000) ; Bowden et al . (2000) ; Tondo et al . (2001) |
Case-fatality | −65% | |||
Older Mood Stabilizer + psychosocial | Disability | −70% | Lithium Carbonate, supportive psychososial treatment | Goodwin et al . (1990) ; Angst et al. (2000) ; Bowden et al . (2000) ; Tondo et al . (2001) ; Lam et al. (2009) |
Case-fatality | −65% | |||
Newer mood stabilizer + psychosocial | Disability | −65% | Sodium Valproate, supportive psychosocial treatment | Goodwin et al. (1990) ; Bowden et al . (1994 , 2000) ; Angst et al . (2000) ; Tondo et al . (2001) ; Lam et al (2009) |
Case-fatality | −65% | |||
Epilepsy | ||||
Older antiepileptic | Remission | 60% | Phenobarbital 100 mg daily | Annegers et al . (1979) ; Goodridge, et al . (1983) ; Placenica et al . (1994) ; Cockerell et al . (1995) , Tudur Smith et al . (2009) |
Disability | −43% | |||
Newer antiepileptic | Remission | 60% | Carbamazepine 600 mg daily | Annegers et al . (1979) ; Goodridge et al . (1983) ; Placenica et al . (1994) ; Cockerell et al . (1995) , Tudur Smith et al . (2009) |
Disability | −43 % |
Treatment . | Outcome . | Efficacy . | Drug/other treatment . | Source . |
---|---|---|---|---|
Depression | ||||
Treatment with older Antidepressants (TCA) | Remission | 29% | Amtriptyline (100 mg daily) | Arroll et al . (2005) ; Andrews et al . (2000) |
Disability | −31% | |||
Treatment with newer Antidepressants (SSRI) | Remission | 28% | Fluoxetine (20 mg daily) | Arroll et al . (2005) ; Andrews et al . (2000) |
Disability | −31% | |||
Psychotherapy | Remission | 28% | Cognitive therapy (16–20 h) | de Maat et al . (2007) ; Andrews et al . (2000) |
Disability | −31% | |||
Comibnation of AD and psychotherapy | Remission | 38% | Amtriptyline/Fluoxetine, cognitive therapy | de Maat et al . (2007) ; Andrews et al . (2000) |
Disability | −31% | |||
Proactive care | Remission | 38% | Amtriptyline/Fluoxetine, cognitive therapy | de Maat et al . (2007) ; Andrews et al . (2000) ; Geddes et al . (2003) |
Disability | −31% | |||
Incidence | −35% | |||
Schizophrenia | ||||
Older antipsychotics | Disability | −13% | Chlorpromazine 300 mg daily/Fluphenazine deconate 25 mg daily | Leutch et al . (1999) |
Newer antipsychotics | Disability | −14% | Risperidone 4 mg daily | Leutch et al . (1999) |
Older antipsychotics + psychosocial treatment | Disability | −23% | Chlorpromazine 100 mg daily/Fluphenazine deconate 25 mg daily, supportive psychosocial treatment | Mojtabai et al . (1998) ; Leutch et al . (1999) |
Newer antipsychotics + psychosocial treatment | Disability | −24% | Risperidone 4 mg daily, supportive psychosocial treatment | Mojtabai et al . (1998) ; Leutch et al . (1999) |
Case-management with older antipsychotics | Disability | −24% | Chlorpromazine 300 mg daily/Fluphenazine deconate 25 mg daily | Mojtabai et al . (1998) ; Leutch et al . (1999) |
Case-management with newer antipsychotics | Disability | −25% | Risperidone 4 mg daily | Mojtabai et al . (1998) ; Leutch et al . (1999) |
Bipolar disorder | ||||
Older mood stabilizer | Disability | −70% | Lithium Carbonate | Goodwin et al. (1990) ; Angst et al . (2000) ; Bowden et al . (2000) ; Tondo et al . (2001) |
Case-fatality | −65% | |||
Newer mood stabilizer | Disability | −65% | Sodium Valproate | Goodwin et al . (1990) ; Bowden et al 1994 ; Angst et al . (2000) ; Bowden et al . (2000) ; Tondo et al . (2001) |
Case-fatality | −65% | |||
Older Mood Stabilizer + psychosocial | Disability | −70% | Lithium Carbonate, supportive psychososial treatment | Goodwin et al . (1990) ; Angst et al. (2000) ; Bowden et al . (2000) ; Tondo et al . (2001) ; Lam et al. (2009) |
Case-fatality | −65% | |||
Newer mood stabilizer + psychosocial | Disability | −65% | Sodium Valproate, supportive psychosocial treatment | Goodwin et al. (1990) ; Bowden et al . (1994 , 2000) ; Angst et al . (2000) ; Tondo et al . (2001) ; Lam et al (2009) |
Case-fatality | −65% | |||
Epilepsy | ||||
Older antiepileptic | Remission | 60% | Phenobarbital 100 mg daily | Annegers et al . (1979) ; Goodridge, et al . (1983) ; Placenica et al . (1994) ; Cockerell et al . (1995) , Tudur Smith et al . (2009) |
Disability | −43% | |||
Newer antiepileptic | Remission | 60% | Carbamazepine 600 mg daily | Annegers et al . (1979) ; Goodridge et al . (1983) ; Placenica et al . (1994) ; Cockerell et al . (1995) , Tudur Smith et al . (2009) |
Disability | −43 % |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.